CSIMarket


Bioventus Inc   (NASDAQ: BVS)
Other Ticker:  
 

Bioventus Inc

BVS's Fundamental analysis








Looking into Bioventus Inc growth rates, revenue grew by 15.6 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 1021

Medical Equipment & Supplies industry recorded growth of revenues by 1.71 %

Bioventus Inc net loss decreased from $-9 millions, to $-5 millions in III. Quarter 2024,

More on BVS's Growth


Bioventus Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 42.34 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.24.
Medical Equipment & Supplies industry's Price to Sales ratio is at 5.14.


More on BVS's Valuation
 
 Total Debt (Millions $) 384
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,111,742
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.38
 Tangible Book Value (Per Share $) -3.61

Bioventus Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 42.34 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.24.
Medical Equipment & Supplies industry's Price to Sales ratio is at 5.14.

Bioventus Inc Price to Book Ratio is at 3.68 higher than Industry Avg. of -200.24, and higher than S&P 500 Avg. of 0.01

More on BVS's Valuation

  Market Capitalization (Millions $) 688
  Shares Outstanding (Millions) 65
  Employees 500
  Revenues (TTM) (Millions $) 556
  Net Income (TTM) (Millions $) -51
  Cash Flow (TTM) (Millions $) 16
  Capital Exp. (TTM) (Millions $) -1
  Total Debt (Millions $) 384
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 1,111,742
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 4.38
  Tangible Book Value (Per Share $) -3.61

  Market Capitalization (Millions $) 688
  Shares Outstanding (Millions) 65
  Employees 500
  Revenues (TTM) (Millions $) 556
  Net Income (TTM) (Millions $) -51
  Cash Flow (TTM) (Millions $) 16
  Capital Exp. (TTM) (Millions $) -1


    BVS's Profitability Comparisons
Bioventus Inc achieved increase in profitability, due to cost control. Operating Margin grew in III. Quarter 2024 to 2.94 %.







  Ratio
   Capital Ratio (MRQ) 1.41
  Total Debt to Equity (MRQ) 2.05
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.71
  Inventory Turnover Ratio (TTM) 2.01



Bioventus Inc achieved increase in profitability, due to cost control. Operating Margin grew in III. Quarter 2024 to 2.94 %.



More on BVS's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com